Over the past decade, enormous progress has been made in the field of induced pluripotent
stem cells (iPSCs). Patients' somatic cells such as skin fibroblasts or blood cells can be used …

The burst of reprogramming technology in recent years has revolutionized the field of stem
cell biology, offering new opportunities for personalized, regenerative therapies. The direct …

Induced pluripotent stem cells (iPSC) were first generated from somatic cells via the
transduction of four 'Yamanaka'factors, Oct4, Sox2, Klf4 and c-Myc. Because iPSC are …

Human pluripotent stem cells represent an accessible cell source for novel cell-based
clinical research and therapies. With the realization of induced pluripotent stem cells …

The breakthrough in human induced pluripotent stem cells (hiPSCs) has revolutionized the
field of biomedical and pharmaceutical research and opened up vast opportunities for drug …

Ten years have passed since the first publication announcing the generation of induced
pluripotent stem cells (iPSCs). Issues related to ethics, immune rejection, and cell availability …

Summary iPSC technology provides unprecedented opportunities in biomedical research
and regenerative medicine. However, there remain a great deal to learn about iPSC safety …

The generation of hematopoietic stem cells (HSCs) from induced pluripotent stem cells
(iPSCs) is an active and promising area of research; however, generating engraftable HSCs …

Since their discovery in 2006, induced pluripotent stem cells (iPSCs) have opened up a
world of possibilities for regenerative medicine and novel cell-based therapeutics. Now, over …

Reprogramming somatic cells into induced pluripotent stem (iPS) cells is nowadays
approaching effectiveness and clinical grade. Potential uses of this technology include …